newsfilter
← Latest News
GlobeNewswire·

Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

GRAND CAYMAN, Cayman Islands, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company developing RNA